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AbstrAct
Objective To determine the feasibility and acceptability 
of a computerised treatment for social anxiety disorder for 
adults who stutter including identification of recruitment, 
retention and completion rates, large cost drivers and 
selection of most appropriate outcome measure(s) to 
inform the design of a future definitive trial. 
Design  Two-group parallel design (treatment vs placebo), 
double-blinded feasibility study. Participants: 31 adults 
who stutter. 
Intervention  Attention training via an online probe 
detection task in which the stimuli were images of faces 
displaying neutral and disgusted expressions. 
Main outcome measures  Psychological measures: 
Structured Clinical Interview Global Assessment of 
Functioning score; Liebowitz Social Anxiety Scale; Social 
Phobia and Anxiety Inventory; State-Trait Anxiety Inventory; 
Unhelpful Thoughts and Beliefs about Stuttering. Speech 
fluency: percent syllables stuttered. Economic evaluation: 
resource use questionnaire; EuroQol three-dimension 
questionnaire. Acceptability: Likert Scale questionnaire 
of experience of trial, acceptability of the intervention and 
randomisation procedure. 
results Feasibility of recruitment strategy was 
demonstrated. Participant feedback indicated that the 
intervention and definitive trial, including randomisation, 
would be acceptable to adults who stutter. Of the 31 
participants who were randomised, 25 provided data at all 
three data collection points.
conclusions The feasibility study informed components 
of the intervention. Modifications to the design are needed 
before a definitive trial can be undertaken.
trial registration number I SRCTN55065978; Post-
results.
IntrODuctIOn
Stuttering is a disorder that affects the 
fluency of speech. The prevalence of stut-
tering among adults has been estimated at 
0.78%.1 Stuttering is strongly associated with 
social anxiety disorder, a persistent and exces-
sive fear of being humiliated, scrutinised or 
negatively evaluated in social situations,2 
which may compromise many aspects of 
life including relationships, education and 
employment. Up to 60% of adults who are 
seeking treatment for stuttering experience 
social anxiety disorder,3 4 compared with 
6.8% of the general adult population.5 In the 
wider population of people who stutter, this 
figure may be the same, or it could be lower 
(eg, those with social anxiety disorder may be 
more likely to seek treatment because of the 
limitations it places on their lives) or higher 
(eg, avoidant tendencies associated with social 
anxiety disorder may make them unwilling to 
seek treatment).1 There is a lack of adequate 
provision of speech and language therapy 
services in the UK6: some areas of the country 
have no service for adults who stutter,7 and 
many speech and language therapists have 
limited formal training in established psycho-
logical therapies.8 With increasing pressure 
on health service resources, an ‘e-mental 
health’ approach,9 involving online delivery 
of an intervention that does not require 
the presence of a trained therapist, could 
provide a cost-effective means of improving 
the psychological health of adults who stutter. 
In addition, e-mental health interventions 
have the potential to be more convenient 
for clients, including those who would other-
wise have to travel long distances to access 
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Research
strengths and limitations of this study
 ► The study represents the first attempt to use 
cognitive bias modification with adults who stutter.
 ► It provides valuable insights into aspects of the 
design and methodology that will enable us to 
improve these features in a future trial.
 ► We were unable to gather information that would 
explain the relatively high attrition rate among those 
who were randomised.
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the service and those for whom travel is difficult, such as 
people with disabilities and parents with young children. 
However, despite the burgeoning availability of online 
therapies for a wide range of conditions, there is a lack of 
evidence regarding their effectiveness.10 
The primary goal of interventions that address social 
anxiety in people who stutter must be improvement in 
mental health status. However, over half of adults who 
stutter cite improvements in speech fluency as their most 
important goal when they seek therapy.11 Some people 
who stutter become so ashamed of their speech disorder 
that they go to great lengths to disguise it via avoid-
ance techniques; in such cases, the stutter is categorised 
as ‘covert’, ‘masked’ or ‘interiorized’.12 13 Adults who 
stutter become more dysfluent in situations that increase 
their social anxiety,13 14 and recent evidence suggests 
that the psychosocial dimension of stuttering must be 
addressed before speech treatment can succeed.15 Given 
the apparent relationship between anxiety and speech 
fluency, in the development of interventions for social 
anxiety in this group, it is desirable to include speech 
fluency as a secondary outcome measure.
Cognitive behavioural therapy (CBT) is an effective 
intervention for social anxiety disorder in adults who 
stutter,4 and recent trials of internet-delivered CBT for 
adults who stutter4 16–18 have produced promising results. 
A CBT package tailored specifically to the needs of 
people who stutter and delivered by a clinical psycholo-
gist improved the psychological health of participants,4 
and an e-mental health version similarly resulted in 
improved psychological outcomes and achieved good 
levels of compliance.16–18 However, CBT does not work 
for everyone,19 and in its traditional face-to-face mode of 
delivery, it requires the availability of a suitably trained 
health professional. Furthermore, despite the negative 
correlation between social anxiety levels and speech 
fluency in adults who stutter,13 14 to the authors’ knowl-
edge, there is no evidence that using CBT to alleviate 
social anxiety also improves speech fluency. It has been 
speculated that the absence of improvements in fluency 
after CBT may be because once social anxiety disorder 
was eliminated, participants no longer feel the need to 
improve fluency by applying speech restructuring tech-
niques learnt in therapy.4 Alternatively, the controlled and 
deliberate processing of threat that is one mechanism in 
CBT20 may reduce the attentional capacity required for 
applying speech restructuring techniques. Whatever the 
explanation for the absence of fluency improvements, 
given these limitations of CBT, is desirable to explore 
other forms of e-therapy that could be used instead of, or 
in conjunction with, CBT or other psychological interven-
tions.4 16–18 An intervention approach that relied on auto-
matic, unconscious mechanisms rather than controlled 
and deliberate processing might allow speech fluency to 
improve when social anxiety is decreased.
Evidence from cognitive research indicates that 
anxious and non-anxious individuals deploy attention 
differently when processing information. For example, in 
the emotional Stroop task, in which participants have to 
name the colour in which words are printed as quickly as 
possible, anxious individuals have longer colour-naming 
times for words with negative connotations (such as failure) 
than for neutral words (such as feature).21 This finding is 
usually interpreted as reflecting interference between the 
automatic processing of the emotional content and the 
colour-naming process, though other explanations have 
been proposed.22 Attentional biases feature heavily in 
cognitive models of social anxiety.23 Selectively attending 
to threat causes and maintains feelings of anxiety.24 In 
particular, socially anxious people have been shown to 
display attentional biases towards negative facial expres-
sions in the early stages of processing.25 26 A technique 
that has been used to demonstrate this is called probe 
detection. For example, in one study that used probe 
detection,26 participants were shown pairs of faces at 
very brief exposure times; the two faces might both have 
a neutral expression, or one face might have a neutral 
expression and the other an emotional expression (angry 
or happy). The participants were asked to respond to a 
visual probe (an upward-pointing or downward-pointing 
arrow) that appeared in the location previously occu-
pied by one of the faces. A participant who was already 
attending to an area of the screen where the probe 
appears should respond relatively quickly to the probe; 
therefore, relatively short reaction times would indicate 
a bias towards the stimulus that previously appeared at 
that location, and relatively long reaction times a bias 
away from the earlier stimulus. Non-anxious individuals 
had an attentional bias towards happy faces and away 
from threatening faces, while those with high levels of 
social anxiety exhibited the opposite pattern, attending 
towards threatening faces and away from happy faces.26 
There is evidence that non-stuttering anxious people are 
initially hypervigilant for potential sources of threat, but 
after about half a second, they then reorient attention 
away from the threat towards more neutral stimuli.27 28 
While initial hypervigilance for threat would increase the 
individual’s awareness of and anxiety about the threat 
that they are concerned about, reorientation of attention 
away from threat stimuli prevents them from exploring 
and potentially reappraising feared stimuli in a way that 
could help them to overcome their fear.
Some findings have suggested that people who stutter 
also have an attentional bias towards negative stimuli 
during the early stages of processing. On the emotional 
Stroop task, adults who stutter had longer reaction times 
to words with negative emotional connotations than 
non-stuttering controls29 30; in one study,29 adults who 
stutter had higher levels of both state and trait anxiety 
than controls, while in the other,30 no measures of anxiety 
were reported. In a probe detection task, children and 
adolescents who stutter and who met screening criteria 
for social anxiety disorder were biased towards looking 
at schematic faces with sad expressions, unlike non-anx-
ious participants who stutter, who were biased away from 
such faces.31 However, in another probe detection task, 
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adults who stutter exhibited the same attentional patterns 
as non-stuttering controls; the stuttering group did not 
differ from controls on a measure of social anxiety, but 
had significantly higher levels of trait anxiety.22 Another 
study found that in a more naturalistic setting where 
speakers had access to visual feedback from an audience 
when they were giving a speech, adults who stutter looked 
less at audience members compared with controls32; the 
stuttering group scored significantly higher than the 
controls on a measure of social anxiety. The latter finding 
may reflect a later stage of processing than the other tasks.
Hypervigilance for social threat can be treated using 
an approach called attention training,33 34 which retrains 
processing patterns so that attention is automatically 
focused away from disapproving facial expressions, with a 
concomitant improvement in levels of social anxiety.21 35 
For example, using the probe detection paradigm, when 
the letter probe systematically replaced neutral rather 
than negative faces, thus training individuals to attend 
away from social threat, there was a significant likeli-
hood that participants would no longer experience social 
anxiety disorder.34
Although attention training has been successfully used 
in non-stuttering individuals with social anxiety disorder, 
there have been no studies to date investigating the use 
of attention training to address social anxiety in adults 
who stutter. It is unknown how this intervention would 
be received by individuals who stutter and whether they 
would even be interested in taking part in such a study. 
Recruitment into intervention trials can be difficult for 
people experiencing mental health problems36 37 and it 
could be the case that having both a stutter and social 
anxiety may make participation even more difficult. 
The Medical Research Council' Complex Interventions 
Framework (https://www. mrc. ac. uk/ documents/ pdf/ 
complex- interventions- guidance/) suggests the use of 
feasibility studies in order to refine the study design 
and to avoid problems around recruitment, retention, 
acceptability, compliance and other aspects of delivery 
in the larger study. Therefore, the present feasibility 
study was conducted to inform the design of a future 
clinical trial. Specifically, we aimed to: develop and 
assess recruitment strategies; assess the suitability of 
outcome measures for a subsequent trial; estimate SD 
for outcome measures to inform subsequent sample 
size calculations; estimate the costs and benefits asso-
ciated with attention training for adults who stutter; 
and investigate whether both the intervention and a 
subsequent randomised controlled trial were likely to 
be acceptable to the target group, including the accept-
ability of random allocation.
MethODs
Design
Two-group parallel design (treatment vs placebo), 
double-blinded, with three data collection points (base-
line, post-treatment (4 weeks), follow-up 2 (4 months)).
Participants and recruitment
As this was a feasibility study, no formal sample size calcu-
lation was carried out, but consistent with recommenda-
tions for sample sizes in feasibility studies,38 we aimed to 
recruit a total of 60 participants. We employed a variety of 
recruitment methods over a 9-month period. The study 
was publicised on the website and social media of the 
British Stammering Association www. stammering. org and 
via their social media, newsletters, open days and self-help 
groups; posters and flyers were displayed in local super-
markets, libraries, general practitioner (GP) practices, 
speech and language therapy clinics, pharmacies and Job 
Centres and at various venues within the University of East 
Anglia and local colleges; a press release was distributed, 
resulting in radio and TV interviews; we publicised the 
trial via the study’s own website and its Twitter account, 
including a sponsored tweet, and study information was 
retweeted to over 4 000 000 Twitter users; we conducted a 
search and mail-out using National Health Service (NHS) 
records (GP surgeries and speech and language therapy 
(SLT) clinics) via searches of data sets using Read Codes 
1B92, 2B49, E270 and Eu9y5, which refer to stuttering/
stammering (see https:// digital. nhs. uk/): we publicised 
the trial in various events for local speech and language 
therapists. People who were interested in participating 
were invited to contact the research team and were then 
sent an information pack if they had not already received 
this (eg, via the search and mail-out process or by access 
the study website). The information pack contained a 
screening questionnaire which they were asked to return 
to the study team. The screening questionnaire included 
the Social Phobia Inventory (SPIN),39 a widely used 
screening instrument for social anxiety disorder, and also 
gathered demographic information and details about 
how respondents heard about the study, their preferred 
means of contact, their level of computer literacy, current 
involvement in stuttering or social anxiety research and 
comorbidity and treatments.
Inclusion and exclusion criteria
Inclusion
Participants had to be at least 18 years old and meet 
the criteria for risk of social anxiety disorder on the 
SPIN.39 An additional criterion relating to stuttering 
rate when measured over the telephone was removed 
when informal feedback suggested that it was a barrier 
to recruitment.
Exclusion
Potential participants were excluded if they reported 
having had CBT during the previous 6 months or speech 
treatment during the previous 12 months, had an intel-
lectual disability, were currently at risk of self-harm or 
suicide, were currently using benzodiazepines or were 
unwilling or unable to maintain a stable dose of any 
extant psychotropic medication for the duration of the 
trial.
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Intervention and placebo conditions
Participants were randomly allocated in blocks of four or 
six to the two conditions using a function within the trial 
data management system at the Norwich Clinical Trials 
Unit. Apart from the research administrator, all other 
individuals were blinded after assignment.
Intervention
The intervention consisted of an online computer task. 
This was programmed and managed by Cambridge 
Brain Sciences (www. cambrid gebr ains cien ces. com) via 
their  CBSTrials. com platform, which enabled the project 
team to monitor compliance and issue reminders to 
participants if necessary, using the preferred means of 
contact indicated by the participant (email, phone, text 
or letter).
A set of 16 face images (63 mm x 44 mm), representing 
eight individuals (four men and four women, repre-
senting a range of ages), was selected from the FACES 
database40 (http:// faces. mpib- berlin. mpg. de/ album/ 
escidoc: 57488). For each individual, one image displayed 
a disgusted expression and the other a neutral expres-
sion. The computer task involved presenting pairs of 
faces simultaneously.
Each 5 min computer session began with a set of practice 
trials (in the experimental design sense) followed by the 
intervention, which consisted of 160 trials. The start of a 
trial was indicated by the appearance of a fixation cross in 
the centre of the screen, which remained for 500 ms and 
on which participants were instructed to focus. A pair of 
faces was then presented for 500 ms. The images within a 
pair represented a single individual. Each pair comprised 
either one face displaying a neutral expression and one 
displaying a disgusted expression (80% of trials), or two 
faces displaying a neutral expression. The two faces were 
separated by 5 degrees of visual angle and were displayed 
centrally on the computer screen on a grey background. 
The faces then disappeared and a letter E or F appeared 
in the location previously occupied by one face. Faces, 
probe letters and probe positions were counterbalanced. 
Participants were instructed to respond to the letter 
probe as quickly and as accurately as possible by pressing 
the appropriate key on their computer keyboard. In the 
intervention condition, the letter only ever replaced 
neutral faces, never disgusted ones.
Participants were asked to complete the online 
computer task twice a week for 4 weeks. They were given 
an opportunity to practise a similar task in the base-
line data collection session, at which they could ask the 
researcher questions if necessary. They were given the 
option of carrying out their eight sessions at home or at 
the Clinical Trials Unit of the University of East Anglia; all 
opted to do so at home. To ensure that the visual material 
was displayed in the same way regardless of the computer 
they were using, participants were asked to indicate the 
dimensions of their computer screen at the start of each 
session.
Placebo
The placebo condition was identical to the experimental 
condition, except that the letter probe was equally likely 
to replace either expression.
ethics and informed consent
Ethical approval for the study was granted by the local 
research ethics committee (National Research Ethics 
Committee East of England–Cambridge South, ref: 12/
EE/0272). All ethical and research governance proce-
dures were in place before the trial began. All participants 
gave individual written consent to take part in the trial.
Data collection
Data collection took place at three time points: baseline 
(prior to commencement of the intervention), post-treat-
ment (approximately 1 week after the final computer 
session) and follow-up (after a further 3 months). 
Outcome measures were as follows:
Psychological measures
The following measures were collected at all three time 
points.
Structured Clinical Interview for DSM–IV–TR Axis I Disor-
ders, Research Version, Non-Patient Edition (SCID).41 The full 
interview was administered at baseline; only the Social 
Anxiety section of the interview was administered at the 
other two time points. The Global Assessment of Func-
tioning score is reported here.
Liebowitz Social Anxiety Scale,42 a 24-item clinician-ad-
ministered assessment that focuses on performance 
anxiety in social situations. The assessment yields separate 
measures for the anxiety experienced by the participant 
in different situations and the extent to which they avoid 
those situations.
Social Phobia and Anxiety Inventory (SPAI),43 a 45-item 
self-report assessment that considers specific somatic 
symptoms, cognitions and behaviours related to social 
anxiety.
State-Trait Anxiety Inventory (STAI),44 a 40-item self-re-
port assessment that distinguishes between the person’s 
temporary, situation-related (state) anxiety and their rela-
tively enduring disposition to experience (trait) anxiety.
Unhelpful Thoughts and Beliefs about Stuttering (UTBAS),45 
a 66-item self-report measure that asks about unhelpful 
thoughts and beliefs that are often reported by people 
who stutter in clinic.
Speech fluency
Speech fluency was measured to enable comparison 
with prior research4 and to determine whether changes 
in social anxiety that might emerge as a result of the 
intervention had an impact on this variable, since prior 
research had suggested a correlation between social 
anxiety and speech fluency.13 The percent syllables stut-
tered speech fluency measure46 was based on an audio 
recording lasting approximately 2–3 min collected at 
each of the three time points. The speech sample was 
elicited by the interviewer following training by the fifth 
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author, a speech and language therapist specialising in 
disorders of fluency. Participants were asked to talk about 
a topic of their own choosing or, if they were unable to 
think of a topic, the interviewer suggested several possibil-
ities, avoiding topics that might cause emotional distress. 
At all three sessions, the speech sample was collected 
early in the interview, before the SCID. The calculation 
of percent syllables stuttered was carried out by the fifth 
author.
Economic evaluation
To inform the design of a full economic evaluation as 
part of a future definitive trial, we estimated question-
naire completion rates, sought to identify how and what 
cost and effect data would be collected and sought to 
identify large cost drivers, where a complete case analysis 
was47 performed with regard to the latter.
Costs were calculated from the perspective of the NHS 
and personal social services.48Healthcare resource use 
data were elicited through a self-completed questionnaire 
administered at baseline and at 4-month follow-up. The 
questionnaire monitored levels of contact with different 
healthcare professionals (eg, speech and language ther-
apists, counsellors and GP services), medications and 
hospital visits and admissions. Costs were assigned to 
each item of resource use using unit costs of health and 
social care49 and NHS Reference Costs data,50 estimated 
at 2012/2013 financial year levels (British pounds). The 
cost of the intervention itself was not included given that 
the intervention had already been developed as part 
of this study and was considered to have a negligible 
ongoing cost.
The EuroQol five-dimension questionnaire 
(EQ-5D-3L)51 including the visual analogue scale 
(EQ-VAS) was used to measure health-related quality 
of life for which responses were sought at baseline, 5 
weeks and 4 months. EQ-5D-3L states were converted 
into utility scores using the York A1 tariff,52 where 0 
is equivalent to death and 1 is full health. Within-trial 
quality-adjusted life year (QALY) scores were subse-
quently estimated using the total area under the curve 
approach.53
Recruitment route
To identify the optimum mode of recruitment, randomised 
participants were asked how they heard about the trial.
Acceptability
A self-completed structured feedback questionnaire using 
5-point Likert responses was administered post-treatment 
to elicit participants' views and experience of partici-
pating in the trial (eg, screening, completion of outcome 
measures), acceptability of the intervention (completion 
of the computerised task) and randomisation.
After follow-up measures were completed, participants 
were informed of their allocation and asked whether they 
thought it was reasonable that they had been allocated to 
this condition.
Participants had the opportunity to make open-ended 
comments both post-treatment and at follow-up about 
their experience of the intervention and participation in 
the trial.
Analysis of psychological and fluency measures
Although this was a feasibility study, an analysis was carried 
out to provide an initial estimate of efficacy for each 
outcome. The between-group difference was expressed as 
a difference in means together with a 95% CI. In addi-
tion, we used Generalised Estimating Equations (GEEs) 
to estimate potential intervention effects based on the 
two follow-up time points simultaneously. This approach 
incorporates the correlation between time points and 
does not need an assumption of independence. The 
models included the baseline values of the dependent 
variable, time point, study group and a time-by-study 
group interaction term. These models assumed normally 
distributed outcomes. These analyses were based on the 
‘intention-to-treat’ population; a secondary analysis was 
carried out based on the intervention actually received. 
The pooled within-group SD for each outcome was calcu-
lated, together with 95% CIs, to inform the sample size of 
future trials.
results
Participant recruitment and retention
A total of 312 information packs containing screening 
questionnaires were sent out: 203 were sent to people 
identified via NHS records, 109 to people requesting 
packs after having heard about the study through other 
routes described above. Forty-nine people (16% of those 
requesting packs) completed the screening questionnaire. 
Figure 1 shows the Consolidated Standards of Reporting 
Trials (CONSORT) flowchart detailing recruitment and 
retention. Of those who did not meet inclusion criteria, 
14 did not meet criteria for risk of social anxiety disorder, 
one person had received treatment for stuttering in the 
previous 12 months and one was unwilling or unable to 
maintain a stable dose of any extant psychotropic medica-
tion for the duration of the trial. Thirty-one participants 
were randomised to the trial, and 25 provided informa-
tion at all three data collection points. Ten participants 
needed to be sent at least one reminder to carry out a 
computer session: eight participants received a single 
reminder, one participant received reminders about two 
sessions and one participant was sent reminders about 
seven sessions. Table 1 shows the baseline characteristics 
of those who were randomised. There were imbalances at 
baseline (eg, in age), but given the relatively small sample 
size, these are not unexpected.
Participants were asked how they heard about the 
trial. In terms of participants randomised, the British 
Stammering Association was the most effective recruit-
ment route (n=9), followed by posters in supermarkets 
(n=5), GP surgeries (5) or SLT clinics (2), GP search and 
mail-out (2) and Twitter (2). Six other methods (study 
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Figure 1 CONSORT flow diagram of the trial conduct. 
website, local media, newsletter, SLT clinic search and 
mail-out, university publicity, word of mouth) resulted in 
a single participant each.
Psychological and fluency outcome measures
Although all participants had scores consistent with risk 
of social anxiety disorder according to the SPIN, only 
three met the full diagnostic criteria in the SCID baseline 
interview. The SCID excludes a diagnosis of social anxiety 
disorder in cases where the anxiety is attributable to stut-
tering, but some researchers in the field of stuttering 
have modified this definition to include such cases.54 55 
According to this modified definition, 17 participants 
(seven in the attention training condition and 10 in the 
placebo condition) met the criteria for a diagnosis of 
social anxiety disorder.
Table 2 summarises data from the psychological and 
speech fluency outcome measures. The crude between-
group mean differences are presented at 5-week and 
4-month follow-up with 95% CIs. These interval esti-
mates are wide and in all but one case included 0 (ie, 
the differences were not statistically significant at the 
5% level). In the case of the SCID, however, a statistically 
significant difference was seen at 4 months. The GEE 
models, however, adjusting for baseline scores, suggested 
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Table 1 Baseline characteristics
Intervention (n=16) Control (n=15)
Demographics
  Age
   Mean (SD) 48.3 (16.2) 39.7 (16.0)
  Gender
   Male
   Female
15 (94%)
1 (6%)
10 (67%)
5 (33%)
  Ethnicity
   White
   Asian
   Black
13 (87%)
1 (7%)
1 (7%)
14 (93%)
1 (7%)
0
  Computer literacy
   <5
   5–6
   >6
3 (19%)
7 (44%)
6 (37%)
5 (33%)
7 (47%)
3 (20%)
  Living alone?
   Yes
   No
2 (13%)
14 (87%)
3 (20%)
12 (80%)
  Employment status
   Employed
   Self-employed
   In education
   Retired
   Unemployed
   Incapacity
8 (50%)
2 (13%)
0
5 (31%)
0
1 (6%)
9 (60%)
2 (13%)
2 (13%)
1 (7%)
1 (7%)
0
  Recruitment route
   Clinical*
   Community†
10 (63%)
6 (38%)
9 (60%)
6 (40%)
*British Stammering Association, GP and SLT poster, GP and SLT 
search and mail out.
†Supermarket poster, Twitter, study website, local media, 
newsletter, university publicity, word of mouth.
no difference in the SCID. There was a significant differ-
ence in the UTBAS between groups but, again, the CI is 
very wide, making any firm conclusions difficult to make. 
There were clear differences with respect to the change 
in scores over time between the two groups for both the 
SPAI and STAI, as evidenced by the significant interac-
tions between time and study group, evidenced from the 
GEE model. These results are reported on an intention-
to-treat basis, but it should be noted that one participant 
who was randomised to the treatment condition actually 
received the placebo. Analysing the outcomes according 
to intervention received made no material difference to 
the results.
Table 3 estimates of the pooled within-group SD (with 
95% CIs) for each of the outcomes at each follow-pe-
riod to aid in sample size calculations. No agreed-upon 
minimally clinically important differences are available 
for these measures within this target population. These 
will be required, through consensus expert opinion, to 
decide an appropriate sample size for a future definitive 
trial.
economic evaluation
The feasibility of conducting an economic evaluation was 
demonstrated by good response rates, with the Health 
Services Resource Use (HSRU) and EQ-5D-3L completed 
by ≥73% participants (online supplementary file 1, 
table 1). Of the 25 participants completing the feasibility 
trial, 22 had complete HSRU and EQ-5D-3L question-
naire data available for complete case analysis (11 control, 
11 intervention).
Given the small number of cases and the feasibility 
design, incremental costs and a recommendation on 
value for money are purposely not reported. Mean costs 
and QALY scores reported below should be interpreted 
with caution.
The source and estimated unit cost for items of resource 
use are displayed in online supplementary file 1, table 2. 
Overall, mean levels of resource use reported were low 
(see online supplementary file 1, table 3). Although 
mean number of prescriptions showed a slight increase 
at follow-up in both arms, these prescriptions were 
not deemed related to the condition. Fifteen per cent 
(27/181) of total NHS healthcare contacts at baseline and 
4 months concerned speech and language therapy, coun-
selling or psychiatry and 17% (38/222) of prescriptions 
over the same period were for antidepressants (based 
on all available data). Total mean NHS costs per partici-
pant (not including the cost of the intervention) over the 
4-month duration of follow-up were £105.83 and £346.27 
for intervention and control groups, respectively (see 
online supplementary file 1, table 3). Costs are largely 
based on participants recruited from a clinical setting 
(17/22), with numbers recruited from community and 
clinical settings evenly distributed across both arms of the 
trial at baseline (table 1). This pattern was repeated when 
restricted to complete cases for the economic evaluation 
(n=22) with 17 from a clinical setting (eight intervention; 
nine control) and 5 from a community setting (three 
intervention; two control).
In the Anxiety/Depression dimension of the EQ-5D-3L, 
47% (14/30) of respondents reported any problem at 
baseline compared with the overall population norm of 
21%.56 Mean baseline, postintervention and follow-up 
scores for the EQ-5D-3L and EQ-VAS are shown in online 
supplementary file 1, table 4, along with the QALY esti-
mate. The mean EQ-5D-3L and EQ-VAS scores were 
similar for intervention and control arms and over all 
three times points. The QALY was similar in both control 
and intervention arms (0.283 and 0.280, respectively). 
It is difficult to conclude that there is any discernible 
pattern to these scores given the small numbers in the 
analyses.
Acceptability
Table 4 summarises data from the feedback questionnaire 
completed post-treatment, when participants had not yet 
been informed of their allocation. Of the 26 participants 
who provided data at this time point, all of those who 
received the placebo (n=12) thought they had received 
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Table 3 Variability in outcome measures: pooled SD with 95% CI
5 weeks follow-up 4 months follow-up
SCID 5.13 (4.00 to 7.19) 8.12 (6.31 to 11.40)
SPAI 31.0 (23.8 to 44.8) 32.5 (24.5 to 48.0)
STAI 10.2 (7.9 to 14.5) 10.0 (7.8 to 14.1)
Leibowitz Anxiety 10.0 (7.7 to 14.2) 11.1 (8.6 to 15.6)
Leibowitz Avoidance 12.2 (9.5 to 17.3) 13.7 (10.6 to 19.2)
UTBAS 44.2 (34.4 to 62.0) 38.4 (30.0 to 53.9)
% Syllables Stuttered 7.71 (5.96 to 10.92) 7.77 (6.04 to 10.89)
Table 4 Data from participant feedback questionnaire post-treatment
Strongly 
disagree
Mostly 
disagree
Neither agree 
nor disagree Mostly agree Strongly agree
I disliked the initial screening 
questionnaire that I filled in.
AT 11 1
Placebo 6 1 6
I didn’t mind having my 
speech recorded over the 
telephone*.
AT 1 1 3 3
Placebo 1 1 2 4 3
Over the time that I was 
involved, I had to spend too 
long having assessments 
done at University of East 
Anglia
AT 12
Placebo 10 2 1
I disliked having my speech 
recorded each time I visited 
UEA
AT 7 2 1 1 1
Placebo 8 4 1
The computer task was easy 
to do.
AT 1 11
Placebo 1 5 7
The computer task took up 
too much time.
AT 10 2
Placebo 8 5
I was happy to be randomly 
allocated to a version of 
computer session even 
though I understand that it 
might have been the placebo 
version.†
AT 1 1 10
Placebo 4 9
*The telephone screen was subsequently omitted.
†At this stage the participant had not been informed of their allocation.
the placebo; 11 (78.6%) of those who received the inter-
vention also believed they had received the placebo; only 
3 participants who received the intervention correctly 
believed that they had done so. At follow-up, they were 
informed of their allocation to attention training or 
placebo and were asked whether they thought it was 
reasonable that they had been allocated to this condi-
tion: only one participant (who had received attention 
training) felt that randomisation was unreasonable.
Participants had an opportunity to make open-ended 
comments both post-treatment and at follow-up. Partic-
ipants made positive comments about the organisation 
and structure of the study, their interaction with the staff, 
their own perception of the effect of the treatment, the 
simplicity of the task, the potential value of such an inter-
vention if effective and their enjoyment of participation. 
Several expressed a wish to know more about the mech-
anism underpinning the treatment (they received infor-
mation about this after data collection was completed). 
One person noted that the print size of one of the ques-
tionnaires was very small. Several remarked that they 
understood the reasons for randomisation.
suitability of outcome measures
Outcome measures were generally found to be suitable, 
but some deserve further comment. The face-to-face 
nature of the SCID interview caused logistical challenges 
in terms of availability of interviewer and participant and 
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may also have had a negative impact on recruitment; in 
future, an equivalent online measure might be prefer-
able. The format of the paper version of the SPAI was such 
that it was very easy to miss items and, as a result, there 
were 1.6% missing values for this measure; in the future, 
it would be better to use a different format or to have 
the researcher check the form while the participant is 
present. Finally, although participants generally reported 
that they did not object to having their speech recorded, 
this measure could be a barrier to recruitment to a future 
trial, and consideration should be given to using a self-re-
port measure instead.
DIscussIOn
Despite a diverse recruitment strategy implemented over 
a period of 9 months, we were only able to randomise 
approximately half of our original target. Furthermore, 
only around 16% of the screening questionnaires that 
were sent out were returned. It is unlikely that our 
recruitment difficulties were due to a low prevalence of 
social anxiety disorder among adults who stutter: studies 
with clinical samples indicate a high prevalence,3 4 and 
studies using community samples report poor psycho-
logical health among adults who stutter.57 58 In general, 
with regard to recruitment and retention, the main lesson 
from this study is that a future trial is likely to need an 
extended recruitment period and wide geographical 
reach, and would require a similarly diverse recruit-
ment strategy which should involve user organisations 
such as the British Stammering Association. By contrast, 
NHS search and mail-out may be a less time-effective 
and cost-effective method with this client group. The 
difficulties experienced with recruitment are similar to 
those outlined in other studies recruiting individuals 
with mental health difficulties.36 37 Mental health studies 
which have had success in recruiting participants have 
highlighted the importance of a flexible and individual-
ised approach to recruitment.59
We do not know the reasons for the 20% attrition 
rate among those who were randomised. It is possible 
that they lost interest in the project because they were 
dubious about the likelihood of success: several partici-
pants remarked that it was difficult to see how a computer 
task could help with anxiety, and the majority of partic-
ipants thought they had been allocated to the placebo 
regardless of their actual allocation. This possible barrier 
to recruitment would need to be addressed in any future 
trial, though in a manner that would not be likely to 
impact on effectiveness. Other factors such as the age of 
participants could also be explored.
With some provisos, the outcome measures were suit-
able and their use in a future study is feasible for the most 
part. The small print size of the SPAI may have led to 
some missing data and was commented on by one of the 
participants, so in a future trial, an alternative format may 
need to be adopted. Considering that the fears of those 
with social anxiety disorder centre on social interaction, 
perhaps it is inevitable that recruitment and retention will 
be challenging in a study that requires repeated face-to-
face interaction with members of the research team. A 
possible solution could be to minimise the face-to-face 
element by using online self-completion measures as 
much as possible. Consideration also needs to be given 
to whether and how data about speech fluency should be 
collected, given that dislike of voice recording could be 
a reason for problems of recruitment and retention. On 
the other hand, there could be some value in collecting 
speech fluency data more regularly, for example, imme-
diately after each computer session. If a speech fluency 
measure is included in a future study, the duration 
of the speech sample as well as the mode of collection 
would need to be considered carefully; the short sample 
collected in the present study was very short and there-
fore might not be representative of the individual’s 
speech, but increasing the length of the speech sample 
would increase participant burden and might have a 
negative impact on recruitment and retention. Further-
more, levels of social anxiety could be particularly high 
among people with a ‘covert’, ‘masked’ or ‘interiorized’ 
stutter12 13 which they keep concealed by adopting avoid-
ance strategies, but a speech fluency measure could be 
misleading in their case.
We have shown that it is feasible to collect resource use 
and EQ-5D data from this population group. However, 
the mean overall costs do not suggest that this popula-
tion places a particular burden on the NHS; indeed, 
direct costs are lower than those reported elsewhere for 
computerised CBT for anxiety and depression in primary 
care.60 It is also likely that many of the services reported 
would have been due to health issues not related to stut-
tering. Similarly, the mean EQ-5D-3L population norm 
score has been estimated to be 0.86,61 which is again not 
noticeably different to the scores for the population in 
this study.
Feedback from participants was generally good. They 
reported that their interaction with the project team was 
positive. They found the computer task undemanding. 
Almost all the participants indicated that they did not 
view the prospect of randomisation negatively. It is likely 
that this form of intervention would be acceptable to 
potential end-users.
cOnclusIOns
Participants in this feasibility study trial felt that the inter-
vention would be valuable and reported few concerns 
about the trial itself. If a definitive Randomised Controlled 
Trial is developed, however, careful consideration will 
need to be given to participant recruitment, mode of 
data collection (online vs face to face) and inclusion of a 
speech fluency measure.
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